• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 4 months ago by International Alliance.
      • This topic was modified 6 years, 4 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Patrick Shuma, Kenya

      Patrick Shuma, Kenya

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • Steven Gallagher, Canada

      Steven Gallagher, Canada

    • Charlie Dourney, USA

      Charlie Dourney, USA

    • Andrea Zicchieri, Italy

      Andrea Zicchieri, Italy
      AndreaZicchieri_conSLAncioItaly

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Motoko Ogasawara, Japan

      Motoko Ogasawara, Japan

    • Elkin Ramiro Gaviria Muñoz, Colombia

      Elkin Ramiro Gaviria Muñoz, Colombia

    • Yolanda Armendariz, Mexico

      Yolanda Armendariz, Mexico

    • Cassio Fernando da Silva, Brazil

      Cassio Fernando da Silva, Brazil

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • Ali Var, Turkey

      Ali Var, Turkey

    • Liz Ogg, Scotland

      Liz Ogg, Scotland

    • Mark Miller, UK

      Mark Miller, UK

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Ching-Liang Chu, Taiwan

      Ching-Liang Chu, Taiwan

    • Claudette Sturk, Canada

      Claudette Sturk, Canada
      Picture2

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Roy Taylor, Ireland

      Roy Taylor, Ireland
      roy

    • Andres Estevez Guersznik, Ireland

      Andres Estevez Guersznik, Ireland

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Mirca Bersani, Italy

      Mirca Bersani, Italy
      MircaBersani

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Ali Var, Turkey

      Ali Var, Turkey

    • Mauricio Dorin, Argentina

      Mauricio Dorin, Argentina

    • Rosie Riley, USA

      Rosie Riley, USA

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Angela Jansen, Germany

      Angela Jansen, Germany

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Liam Dwyer, England

      Liam Dwyer, England

    • Sanjay Kumar Srivastava, India

      Sanjay Kumar Srivastava, India

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • João Marcos Andrietta, Brazil

      João Marcos Andrietta, Brazil

    • David Watson, Scotland

      David Watson, Scotland

    • Paul Launer, USA

      Paul Launer, USA

    • Michael Lee, Australia

      Michael Lee, Australia

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Orlando Ruiz, Colombia

      Orlando Ruiz, Colombia

    • Conny van der Meijden, Netherlands

      Conny van der Meijden, Netherlands

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Eddy LeFrançois, Canada

      Eddy LeFrançois, Canada

    • Daniel Hare, USA

      Daniel Hare, USA

    • Sally Pauls, USA

      Sally Pauls, USA

    • Hanne Stenmose, Denmark

      Hanne Stenmose, Denmark

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • Guido De Mets, Belgium

      Guido De Mets, Belgium

    • Armando González Gómez, Colombia

      Armando González Gómez, Colombia

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login